{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:28:31Z","timestamp":1790674111874,"version":"4.1.0"},"reference-count":230,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>The development of a modified stromal microenvironment in response to neoplastic onset is a common feature of many tumors including cutaneous melanoma. At all stages, melanoma cells are embedded in a complex tissue composed by extracellular matrix components and several different cell populations. Thus, melanomagenesis is not only driven by malignant melanocytes, but also by the altered communication between melanocytes and non-malignant cell populations, including fibroblasts, endothelial and immune cells. In particular, cancer-associated fibroblasts (CAFs), also referred as melanoma-associated fibroblasts (MAFs) in the case of melanoma, are the most abundant stromal cells and play a significant contextual role in melanoma initiation, progression and metastasis. As a result of dynamic intercellular molecular dialogue between tumor and the stroma, non-neoplastic cells gain specific phenotypes and functions that are pro-tumorigenic. Targeting MAFs is thus considered a promising avenue to improve melanoma therapy. Growing evidence demonstrates that aberrant regulation of oncogenic signaling is not restricted to transformed cells but also occurs in MAFs. However, in some cases, signaling pathways present opposite regulation in melanoma and surrounding area, suggesting that therapeutic strategies need to carefully consider the tumor\u2013stroma equilibrium. In this novel review, we analyze four major signaling pathways implicated in melanomagenesis, TGF-\u03b2, MAPK, Wnt\/\u03b2-catenin and Hyppo signaling, from the complementary point of view of tumor cells and the microenvironment.<\/jats:p>","DOI":"10.3390\/cancers12113400","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T07:23:28Z","timestamp":1605597808000},"page":"3400","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A Framework of Major Tumor-Promoting Signal Transduction Pathways Implicated in Melanoma-Fibroblast Dialogue"],"prefix":"10.3390","volume":"12","author":[{"given":"Barbara","family":"Bellei","sequence":"first","affiliation":[{"name":"Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5316-8937","authenticated-orcid":false,"given":"Emilia","family":"Migliano","sequence":"additional","affiliation":[{"name":"Department of Plastic and Regenerative Surgery, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Picardo","sequence":"additional","affiliation":[{"name":"Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1535-6108(02)00161-7","article-title":"Focus on Melanoma","volume":"2","author":"Houghton","year":"2002","journal-title":"Cancer Cell."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/jdv.12236","article-title":"Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015","volume":"28","author":"Arnold","year":"2014","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3389\/fonc.2020.00951","article-title":"Ultraviolet radiation and melanomagenesis: From mechanism to immunotherapy","volume":"10","author":"Sun","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11912-018-0733-7","article-title":"Italian Melanoma Intergroup (IMI). Molecular pathways in melanomagenesis: What we learned from next-generation sequencing approaches","volume":"20","author":"Palmieri","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","article-title":"Cutaneous melanoma","volume":"383","author":"Eggermont","year":"2014","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"a015388","DOI":"10.1101\/cshperspect.a015388","article-title":"Melanoma: Clinical features and genomic insights","volume":"4","author":"Hawryluk","year":"2014","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/jnci\/dji176","article-title":"MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a mediterranean population","volume":"97","author":"Landi","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/phpp.12329","article-title":"Mechanisms and prevention of UV-induced melanoma","volume":"34","author":"Sample","year":"2018","journal-title":"Photodermatol. Photoimmunol. Photomed."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/CCO.0b013e3283252fc5","article-title":"Indoor ultraviolet tanning and skin cancer: Health risks and opportunities","volume":"21","author":"Schulman","year":"2009","journal-title":"Curr. Opin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/em.22370","article-title":"Solar ultraviolet-induced DNA damage response: Melanocytes story in transformation to environmental melanomagenesis","volume":"61","author":"Sarkar","year":"2020","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5114\/pdia.2013.33376","article-title":"Skin melanocytes: Biology and development","volume":"30","author":"Cichorek","year":"2013","journal-title":"Postepy Dermatol. Alergol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.1005244107","article-title":"Melanocytes are deficient in repair of oxidative DNA damage and UV-induced photoproducts","volume":"107","author":"Wang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/em.22176","article-title":"Roles of UVA radiation and DNA damage responses in melanoma pathogenesis","volume":"59","author":"Khan","year":"2018","journal-title":"Env. Mol. Mutagen."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2019.03.008","article-title":"Macroenvironment-gene-microenvironment interactions in ultraviolet radiation-induced melanomagenesis","volume":"144","author":"Mo","year":"2019","journal-title":"Adv. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1177\/0963689717725755","article-title":"Fighting against skin aging: The way from bench to bedside","volume":"27","author":"Zhang","year":"2018","journal-title":"Cell Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.maturitas.2011.04.011","article-title":"Molecular aspects of skin ageing","volume":"69","author":"Naylor","year":"2011","journal-title":"Maturitas"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1365-2133.2007.08108.x","article-title":"Photoageing: Mechanism, prevention and therapy","volume":"157","author":"Yaar","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1346-8138.2011.01441.x","article-title":"Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma","volume":"39","author":"Chen","year":"2012","journal-title":"J. Dermatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13402-012-0080-x","article-title":"MMP2 expression is a prognostic marker for primary melanoma patients","volume":"35","author":"Rotte","year":"2012","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"ref_22","first-page":"8306","article-title":"Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling","volume":"61","author":"Berking","year":"2001","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1364\/OE.14.009770","article-title":"Imaging the mechanical stiffness of skin lesions by in vivo acousto-optical elastography","volume":"14","author":"Kirkpatrick","year":"2006","journal-title":"Opt. Express"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/s41388-018-0209-0","article-title":"Collagen abundance controls melanoma phenotypes through lineage-specific microenvironment sensing","volume":"37","author":"Miskolczi","year":"2018","journal-title":"Oncogene"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nchembio.1548","article-title":"Multifaceted pathways protect human skin from UV radiation","volume":"10","author":"Natarajan","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12079-016-0349-3","article-title":"Crosstalk in skin: Melanocytes, keratinocytes, stem cells, and melanoma","volume":"10","author":"Wang","year":"2016","journal-title":"J. Cell. Commun. Signal."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1755-148X.2010.00673.x","article-title":"MC1R stimulation by alpha-MSH induces catalase and promotes its Re-distribution to the cell periphery and dendrites","volume":"23","author":"Maresca","year":"2010","journal-title":"Pigment Cell. Melanoma Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1365-2133.2005.06780.x","article-title":"Differential expression of melanoma-associated growth factors in keratinocytes and fibroblasts by ultraviolet A and ultraviolet B radiation","volume":"153","author":"Brenner","year":"2005","journal-title":"Br. J. Dermatol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0002-9440(10)64041-2","article-title":"Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin","volume":"158","author":"Berking","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1111\/j.1365-2133.2010.09946.x","article-title":"Role of fibroblast-derived growth factors in regulating hyperpigmentation of solar lentigo","volume":"163","author":"Kovacs","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jdermsci.2010.06.006","article-title":"Immuno-histochemical evaluation of solar lentigines: The association of KGF\/KGFR and other factors with lesion development","volume":"59","author":"Lin","year":"2010","journal-title":"J. Dermatol. Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/pcmr.12684","article-title":"Melasma, a photoaging disorder","volume":"31","author":"Passeron","year":"2018","journal-title":"Pigment Cell. Melanoma Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1600-0749.2003.00126.x","article-title":"Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders","volume":"17","author":"Imokawa","year":"2004","journal-title":"Pigment Cell Res."},{"key":"ref_34","first-page":"114","article-title":"Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis","volume":"9","author":"Mellone","year":"2016","journal-title":"Aging (Albany N. Y.)"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"12173","DOI":"10.1002\/jcp.27955","article-title":"Transforming growth factor-\u03b2 signaling: Tumorigenesis and targeting for cancer therapy","volume":"234","author":"Ahmadi","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11684-018-0646-8","article-title":"Intracellular and extracellular TGF-\u03b2 signaling in cancer: Some recent topics","volume":"12","author":"Miyazono","year":"2018","journal-title":"Front. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1615\/CritRevOncog.2014010630","article-title":"Senescence and the pro-tumorigenic stroma","volume":"18","author":"Alspach","year":"2013","journal-title":"Crit. Rev. Oncog."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"6874","DOI":"10.1158\/0008-5472.CAN-13-1720","article-title":"Senescent fibroblasts in melanoma initiation and progression: An integrated theoretical, experimental, and clinical approach","volume":"73","author":"Kim","year":"2013","journal-title":"Cancer Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/modpathol.2008.28","article-title":"Macro-environment of breast carcinoma: Frequent genetic alterations in the normal appearing skins of patients with breast cancer","volume":"21","author":"Moinfar","year":"2008","journal-title":"Mod. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":"Prognostic factors analysis of 17,600 melanoma patients: Validation of the american joint committee on cancer melanoma staging system","volume":"19","author":"Balch","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: The dark side of tumor suppression","volume":"5","author":"Desprez","year":"2010","journal-title":"Annu. Rev. Pathol."},{"key":"ref_42","first-page":"482","article-title":"Cancer associated fibroblasts: The dark side of the coin","volume":"1","author":"Cirri","year":"2011","journal-title":"Am. J. Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.4161\/cc.21384","article-title":"Metabolic reprogramming of cancer-associated fibroblasts by TGF-\u03b2 drives tumor growth: Connecting TGF-\u03b2 signaling with \"warburg-like\" cancer metabolism and L-lactate production","volume":"11","author":"Guido","year":"2012","journal-title":"Cell. Cycle"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1517\/14728222.9.6.1217","article-title":"Exploring the tumour environment: Cancer-associated fibroblasts as targets in cancer therapy","volume":"9","author":"Micke","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"100981","DOI":"10.1016\/j.arr.2019.100981","article-title":"Premature cell senescence in human skin: Dual face in chronic acquired pigmentary disorders","volume":"57","author":"Bellei","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/pcmr.12736","article-title":"Bad Company: Microenvironmentally mediated resistance to targeted therapy in melanoma","volume":"32","author":"Almeida","year":"2019","journal-title":"Pigment Cell. Melanoma Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajpath.2019.09.006","article-title":"Insights into fibroblast plasticity: Cellular communication network 2 is required for activation of cancer-associated fibroblasts in a murine model of melanoma","volume":"190","author":"Tsang","year":"2020","journal-title":"Am. J. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00008390-199604000-00007","article-title":"E-cadherin expression in human melanoma","volume":"6","author":"Danen","year":"1996","journal-title":"Melanoma Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/S0002-9440(10)65023-7","article-title":"E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors","volume":"156","author":"Hsu","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/(SICI)1096-9896(199812)186:4<350::AID-PATH181>3.0.CO;2-K","article-title":"E-cadherin\/catenin complex in benign and malignant melanocytic lesions","volume":"186","author":"Silye","year":"1998","journal-title":"J. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1432-0436.2002.700906.x","article-title":"Melanoma development and progression: A conspiracy between tumor and host","volume":"70","author":"Hsu","year":"2002","journal-title":"Differentiation"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/mp.52.3.151","article-title":"Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours","volume":"52","author":"Sanders","year":"1999","journal-title":"Mol. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-0749.2005.00235.x","article-title":"Adhesion, migration and communication in melanocytes and melanoma","volume":"18","author":"Haass","year":"2005","journal-title":"Pigment Cell Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1242\/jcs.107.4.983","article-title":"E-cadherin is the major mediator of human melanocyte adhesion to keratinocytes in vitro","volume":"107","author":"Tang","year":"1994","journal-title":"J. Cell. Sci."},{"key":"ref_55","first-page":"3819","article-title":"N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells","volume":"61","author":"Li","year":"2001","journal-title":"Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1038\/sj.onc.1206455","article-title":"Function and regulation of melanoma-stromal fibroblast interactions: When seeds meet soil","volume":"22","author":"Li","year":"2003","journal-title":"Oncogene"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"8509","DOI":"10.1038\/sj.onc.1207831","article-title":"Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma","volume":"23","author":"Kuphal","year":"2004","journal-title":"Oncogene"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"459","DOI":"10.4161\/cbt.1.5.158","article-title":"Cellular adhesion pathways and metastatic potential of human melanoma","volume":"1","author":"McGary","year":"2002","journal-title":"Cancer Biol. Ther."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1083\/jcb.148.4.779","article-title":"Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis","volume":"148","author":"Hazan","year":"2000","journal-title":"J. Cell Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm2258","article-title":"Melanosomes\u2014dark organelles enlighten endosomal membrane transport","volume":"8","author":"Raposo","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/ncb3399","article-title":"Melanoma miRNA trafficking controls tumour primary niche formation","volume":"18","author":"Dror","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.4161\/cc.8.10.8557","article-title":"On the origin of cancer-associated fibroblasts","volume":"8","author":"Anderberg","year":"2009","journal-title":"Cell. Cycle"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12967-020-02376-y","article-title":"Antifibrotic therapy to normalize the tumor microenvironment","volume":"18","author":"Hauge","year":"2020","journal-title":"J. Transl. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4161\/cam.20377","article-title":"The role of the myofibroblast in tumor stroma remodeling","volume":"6","author":"Otranto","year":"2012","journal-title":"Cell. Adh. Migr."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semcdb.2009.10.002","article-title":"Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression","volume":"21","author":"Shimoda","year":"2010","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_66","first-page":"1","article-title":"Melanoma-associated fibroblasts impair CD8+\u2009T cell function and modify expression of immune checkpoint regulators via increased arginase activity","volume":"77","author":"Cakir","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"717","DOI":"10.7150\/jca.10865","article-title":"Perspective of targeting cancer-associated fibroblasts in melanoma","volume":"6","author":"Zhou","year":"2015","journal-title":"J. Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/ncb3404","article-title":"Melanosomes foster a tumour niche by activating CAFs","volume":"18","author":"Peinado","year":"2016","journal-title":"Nat. Cell Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41416-019-0509-3","article-title":"Cancer-associated fibroblasts-heroes or villains?","volume":"121","author":"Gieniec","year":"2019","journal-title":"Br. J. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1002\/cam4.707","article-title":"Dermal fibroblasts induce cell cycle arrest and block epithelial-mesenchymal transition to inhibit the early stage melanoma development","volume":"5","author":"Zhou","year":"2016","journal-title":"Cancer Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1073\/pnas.88.14.6028","article-title":"Fibroblast cell interactions with human melanoma cells affect tumor cell growth as a function of tumor progression","volume":"88","author":"Cornil","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"14235","DOI":"10.1007\/s13277-016-5293-6","article-title":"Targeted deactivation of cancer-associated fibroblasts by \u03b2-catenin ablation suppresses melanoma growth","volume":"37","author":"Zhou","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/carcin\/bgn232","article-title":"Modulated expression of WFDC1 during carcinogenesis and cellular senescence","volume":"30","author":"Madar","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jprot.2017.12.013","article-title":"Signatures of protein expression revealed by secretome analyses of cancer associated fibroblasts and melanoma cell lines","volume":"174","author":"Liberato","year":"2018","journal-title":"J. Proteomics"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"140525","DOI":"10.1016\/j.bbapap.2020.140525","article-title":"Heterotypic signaling between dermal fibroblasts and melanoma cells induces phenotypic plasticity and proteome rearrangement in malignant cells","volume":"1868","author":"Pessotti","year":"2020","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/ijc.24463","article-title":"The invasive potential of human melanoma cell lines correlates with their ability to alter fibroblast gene expression in vitro and the stromal microenvironment in vivo","volume":"125","author":"Li","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"9215","DOI":"10.1073\/pnas.89.19.9215","article-title":"Interleukin 6: A fibroblast-derived growth inhibitor of human melanoma cells from early but not advanced stages of tumor progression","volume":"89","author":"Lu","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00418-016-1433-8","article-title":"Simultaneous blocking of IL-6 and IL-8 is sufficient to fully inhibit CAF-induced human melanoma cell invasiveness","volume":"146","author":"Jobe","year":"2016","journal-title":"Histochem. Cell Biol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"20847","DOI":"10.1073\/pnas.0906481106","article-title":"Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity","volume":"106","author":"Balsamo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.surg.2005.06.031","article-title":"Normal human fibroblasts enable melanoma cells to induce angiogenesis in type I collagen","volume":"138","author":"Goldstein","year":"2005","journal-title":"Surgery"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ccr.2014.04.021","article-title":"Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma","volume":"25","author":"Rhim","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ccell.2015.11.002","article-title":"Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival","volume":"28","author":"Carstens","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-386035-4.00002-1","article-title":"New insights into the mechanism of Wnt signaling pathway activation","volume":"291","author":"Kikuchi","year":"2011","journal-title":"Int. Rev. Cell. Mol. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1242\/dev.033910","article-title":"Towards an integrated view of Wnt signaling in development","volume":"136","author":"Nusse","year":"2009","journal-title":"Development"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: Components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e1356900","DOI":"10.1080\/21688370.2017.1356900","article-title":"Cadherin-mediated cell-cell interactions in normal and cancer cells","volume":"5","author":"Gloushankova","year":"2017","journal-title":"Tissue Barriers"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1080\/01635581.2017.1320415","article-title":"E-cadherin\/\u03b2-catenin complex: A target for anticancer and antimetastasis plants\/plant-derived compounds","volume":"69","author":"Tafrihi","year":"2017","journal-title":"Nutr. Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1126\/science.280.5363.596","article-title":"Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta","volume":"280","author":"Behrens","year":"1998","journal-title":"Science"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Hrckulak, D., Kolar, M., Strnad, H., and Korinek, V. (2016). TCF\/LEF transcription factors: An update from the internet resources. Cancers, 8.","DOI":"10.3390\/cancers8070070"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1101\/gad.14.2.158","article-title":"Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway","volume":"14","author":"Dorsky","year":"2000","journal-title":"Genes Dev."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"8914","DOI":"10.1128\/MCB.02299-05","article-title":"The microphthalmia-associated transcription factor Mitf interacts with beta-catenin to determine target gene expression","volume":"26","author":"Schepsky","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1034\/j.1600-0749.2003.00039.x","article-title":"Microphthalmia-associated transcription factor in the Wnt signaling pathway","volume":"16","author":"Saito","year":"2003","journal-title":"Pigment Cell Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2741\/1831","article-title":"The WNT\/beta-catenin pathway in melanoma","volume":"11","author":"Larue","year":"2006","journal-title":"Front. Biosci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/j.cellsig.2008.06.001","article-title":"GSK3beta inhibition promotes melanogenesis in mouse B16 melanoma cells and normal human melanocytes","volume":"20","author":"Bellei","year":"2008","journal-title":"Cell. Signal."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1755-148X.2010.00800.x","article-title":"Wnt\/\u03b2-catenin signaling is stimulated by \u03b1-melanocyte-stimulating hormone in melanoma and melanocyte cells: Implication in cell differentiation","volume":"24","author":"Bellei","year":"2011","journal-title":"Pigment Cell. Melanoma Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1034\/j.1600-0749.2003.00050.x","article-title":"Beta-catenin in the melanocyte lineage","volume":"16","author":"Larue","year":"2003","journal-title":"Pigment Cell Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1083\/jcb.200209039","article-title":"Lineage-specific requirements of beta-catenin in neural crest development","volume":"159","author":"Hari","year":"2002","journal-title":"J. Cell Biol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/dvdy.20091","article-title":"Cellular localization and signaling activity of beta-catenin in migrating neural crest cells","volume":"230","author":"Desban","year":"2004","journal-title":"Dev. Dyn."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1038\/jid.2013.235","article-title":"Wnt\/\u03b2-catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB-induced epidermal pigmentation","volume":"133","author":"Yamada","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jid.2017.09.040","article-title":"Repigmentation of human vitiligo skin by NBUVB is controlled by transcription of GLI1 and activation of the \u03b2-catenin pathway in the hair follicle bulge stem cells","volume":"138","author":"Goldstein","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/modpathol.3800181","article-title":"Frequent beta-catenin overexpression without exon 3 mutation in cutaneous lymphomas","volume":"17","author":"Bellei","year":"2004","journal-title":"Mod. Pathol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cell.2006.10.018","article-title":"Wnt\/beta-catenin signaling in development and disease","volume":"127","author":"Clevers","year":"2006","journal-title":"Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12015-014-9515-2","article-title":"Wnt\/catenin signaling in adult stem cell physiology and disease","volume":"10","author":"Ring","year":"2014","journal-title":"Stem Cell. Rev. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tcb.2018.08.005","article-title":"WNT signaling in cancer immunosurveillance","volume":"29","author":"Galluzzi","year":"2019","journal-title":"Trends Cell Biol."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Sinnberg, T., Menzel, M., Ewerth, D., Sauer, B., Schwarz, M., Schaller, M., Garbe, C., and Schittek, B. (2011). \u0392-catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023429"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0002-9440(10)65278-9","article-title":"Frequent nuclear\/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma","volume":"154","author":"Rimm","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/ijc.1270","article-title":"Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma","volume":"92","author":"Omholt","year":"2001","journal-title":"Int. J. Cancer"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/modpathol.3880546","article-title":"Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations","volume":"15","author":"Demunter","year":"2002","journal-title":"Mod. Pathol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1038\/sj.onc.1207647","article-title":"Genetic and epigenetic alterations of the APC gene in malignant melanoma","volume":"23","author":"Worm","year":"2004","journal-title":"Oncogene"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/ijc.10512","article-title":"Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC","volume":"100","author":"Reifenberger","year":"2002","journal-title":"Int. J. Cancer"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/gcc.20567","article-title":"Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma","volume":"47","author":"Castiglia","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1126\/science.275.5307.1790","article-title":"Stabilization of beta-catenin by genetic defects in melanoma cell lines","volume":"275","author":"Rubinfeld","year":"1997","journal-title":"Science"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1038\/sj.onc.1209508","article-title":"Expression of dickkopf genes is strongly reduced in malignant melanoma","volume":"25","author":"Kuphal","year":"2006","journal-title":"Oncogene"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1365-2133.2012.10867.x","article-title":"Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma","volume":"166","author":"Huynh","year":"2012","journal-title":"Br. J. Dermatol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejca.2017.03.012","article-title":"Baseline \u03b2-catenin, programmed death-ligand 1 expression and tumour-infiltrating lymphocytes predict response and poor prognosis in BRAF inhibitor-treated melanoma patients","volume":"78","author":"Massi","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Gajos-Michniewicz, A., and Czyz, M. (2020). WNT signaling in melanoma. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21144852"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11912-010-0114-3","article-title":"A re-evaluation of the \u201concogenic\u201d nature of Wnt\/beta-catenin signaling in melanoma and other cancers","volume":"12","author":"Lucero","year":"2010","journal-title":"Curr. Oncol. Rep."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1755-148X.2009.00600.x","article-title":"Secrets to developing Wnt-age melanoma revealed","volume":"22","author":"Larue","year":"2009","journal-title":"Pigment Cell. Melanoma Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1083\/jcb.200202049","article-title":"Beta-Catenin-induced melanoma growth requires the downstream target microphthalmia-associated transcription factor","volume":"158","author":"Widlund","year":"2002","journal-title":"J. Cell Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1073\/pnas.0811902106","article-title":"Activated Wnt\/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model","volume":"106","author":"Chien","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1038\/onc.2011.162","article-title":"In melanoma, beta-catenin is a suppressor of invasion","volume":"30","author":"Arozarena","year":"2011","journal-title":"Oncogene"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1038\/onc.2012.229","article-title":"Beta-catenin inhibits melanocyte migration but induces melanoma metastasis","volume":"32","author":"Gallagher","year":"2013","journal-title":"Oncogene"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1158\/1078-0432.CCR-05-0011","article-title":"Importance of p-cadherin, beta-catenin, and Wnt5a\/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma","volume":"11","author":"Bachmann","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1365-2133.2001.04336.x","article-title":"Loss of beta-catenin expression associated with disease progression in malignant melanoma","volume":"145","author":"Kageshita","year":"2001","journal-title":"Br. J. Dermatol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00428-019-02533-9","article-title":"\u0392-catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors","volume":"474","author":"Caillot","year":"2019","journal-title":"Virchows Arch."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1158\/0008-5472.CAN-07-2491","article-title":"In vivo switching of human melanoma cells between proliferative and invasive states","volume":"68","author":"Hoek","year":"2008","journal-title":"Cancer Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/CMR.0b013e32833bd89e","article-title":"The immunohistochemistry of invasive and proliferative phenotype switching in melanoma: A case report","volume":"20","author":"Eichhoff","year":"2010","journal-title":"Melanoma Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"43295","DOI":"10.18632\/oncotarget.9232","article-title":"The role of Wnt\/\u03b2-catenin signaling pathway in melanoma epithelial-to-mesenchymal-like switching: Evidences from patients-derived cell lines","volume":"7","author":"Kovacs","year":"2016","journal-title":"Oncotarget"},{"key":"ref_129","first-page":"244","article-title":"The Wnts of change: How Wnts regulate phenotype switching in melanoma","volume":"1856","author":"Webster","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1172\/JCI95351","article-title":"\u0392-catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas","volume":"128","author":"Nsengimana","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3389\/fimmu.2019.02293","article-title":"WNT\/\u03b2-catenin signaling pathway regulating T cell-inflammation in the tumor microenvironment","volume":"10","author":"Li","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","article-title":"WNT\/\u03b2-catenin pathway activation correlates with immune exclusion across human cancers","volume":"25","author":"Luke","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1016\/j.ymthe.2018.09.005","article-title":"RNAi-mediated \u03b2-catenin inhibition promotes T cell infiltration and antitumor activity in combination with immune checkpoint blockade","volume":"26","author":"Ganesh","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"ra3","DOI":"10.1126\/scisignal.2002274","article-title":"Wnt\/\u03b2-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma","volume":"5","author":"Biechele","year":"2012","journal-title":"Sci. Signal."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.4161\/cc.21645","article-title":"Regulating the response to targeted MEK inhibition in melanoma: Enhancing apoptosis in NRAS- and BRAF-mutant melanoma cells with Wnt\/\u03b2-catenin activation","volume":"11","author":"Conrad","year":"2012","journal-title":"Cell. Cycle"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Chien, A.J., Haydu, L.E., Biechele, T.L., Kulikauskas, R.M., Rizos, H., Kefford, R.F., Scolyer, R.A., Moon, R.T., and Long, G.V. (2014). Targeted BRAF inhibition impacts survival in melanoma patients with high levels of Wnt\/\u03b2-catenin signaling. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094748"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ceb.2007.02.007","article-title":"Wnt\/beta-catenin signaling in cancer stemness and malignant behavior","volume":"19","author":"Fodde","year":"2007","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10456-019-09688-8","article-title":"Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer","volume":"23","author":"Unterleuthner","year":"2020","journal-title":"Angiogenesis"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"5460","DOI":"10.1038\/onc.2017.144","article-title":"Autocrine WNT2 signaling in fibroblasts promotes colorectal cancer progression","volume":"36","author":"Kramer","year":"2017","journal-title":"Oncogene"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/sj.onc.1209859","article-title":"A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth","volume":"26","author":"Rasola","year":"2007","journal-title":"Oncogene"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cell.2006.08.036","article-title":"P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing axin from beta-catenin","volume":"127","author":"Yang","year":"2006","journal-title":"Cell"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature17392","article-title":"SFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance","volume":"532","author":"Kaur","year":"2016","journal-title":"Nature"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/35020115","article-title":"Molecular classification of cutaneous malignant melanoma by gene expression profiling","volume":"406","author":"Bittner","year":"2000","journal-title":"Nature"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1535-6108(02)00045-4","article-title":"Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma","volume":"1","author":"Weeraratna","year":"2002","journal-title":"Cancer Cell"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/mp.56.5.280","article-title":"Wnt ligand expression in malignant melanoma: Pilot study indicating correlation with histopathological features","volume":"56","author":"Pham","year":"2003","journal-title":"Mol. Pathol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41419-018-0818-0","article-title":"Crosstalk between hepatic tumor cells and macrophages via Wnt\/\u03b2-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors","volume":"9","author":"Yang","year":"2018","journal-title":"Cell. Death Dis."},{"key":"ref_148","first-page":"713","article-title":"Multi-layered prevention and treatment of chronic inflammation, organ fibrosis and cancer associated with canonical WNT\/\u03b2-catenin signaling activation (review)","volume":"42","author":"Katoh","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Baarsma, H.A., Spanjer, A.I., Haitsma, G., Engelbertink, L.H., Meurs, H., Jonker, M.R., Timens, W., Postma, D.S., Kerstjens, H.A., and Gosens, R. (2011). Activation of WNT\/\u03b2-catenin signaling in pulmonary fibroblasts by TGF-\u03b21 is increased in chronic obstructive pulmonary disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0025450"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0002-9440(10)64282-4","article-title":"Aberrant Wnt\/beta-catenin pathway activation in idiopathic pulmonary fibrosis","volume":"162","author":"Chilosi","year":"2003","journal-title":"Am. J. Pathol."},{"key":"ref_151","first-page":"2106","article-title":"Wnt1 inducible signaling pathway protein-3 regulation and microsatellite structure in arthritis","volume":"31","author":"Cheon","year":"2004","journal-title":"J. Rheumatol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/labinvest.3700237","article-title":"Prolonged beta-catenin stabilization and Tcf-dependent transcriptional activation in hyperplastic cutaneous wounds","volume":"85","author":"Cheon","year":"2005","journal-title":"Lab. Investig."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/ncomms1734","article-title":"Activation of canonical Wnt signalling is required for TGF-\u03b2-mediated fibrosis","volume":"3","author":"Akhmetshina","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jid.2016.03.029","article-title":"What lies beneath: Wnt\/\u03b2-catenin signaling and cell fate in the lower dermis","volume":"136","author":"Jahoda","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.jid.2016.01.036","article-title":"\u0392-catenin stabilization in skin fibroblasts causes fibrotic lesions by preventing adipocyte differentiation of the reticular dermis","volume":"136","author":"Mastrogiannaki","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41392-019-0100-7","article-title":"The \u03b2-catenin\/YAP signaling axis is a key regulator of melanoma-associated fibroblasts","volume":"4","author":"Liu","year":"2019","journal-title":"Signal. Transduct. Target. Ther."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/pcmr.12657","article-title":"Suppression of MAPK signaling in BRAF-activated PTEN-deficient melanoma by blocking \u03b2-catenin signaling in cancer-associated fibroblasts","volume":"31","author":"Zhou","year":"2018","journal-title":"Pigment Cell. Melanoma Res."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Shao, H., Kong, R., Ferrari, M.L., Radtke, F., Capobianco, A.J., and Liu, Z.J. (2015). Notch1 pathway activity determines the regulatory role of cancer-associated fibroblasts in melanoma growth and invasion. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142815"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"20395","DOI":"10.1038\/srep20395","article-title":"Extracellular matrix stiffness dictates Wnt expression through integrin pathway","volume":"6","author":"Du","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2019.03.018","article-title":"Dysregulation of the hippo pathway signaling in aging and cancer","volume":"143","author":"Yeung","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo pathway in organ size control, tissue homeostasis, and cancer","volume":"163","author":"Yu","year":"2015","journal-title":"Cell"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrc3458","article-title":"The hippo pathway and human cancer","volume":"13","author":"Harvey","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1158\/1541-7786.MCR-18-0407","article-title":"Somatic hypermutation of the YAP oncogene in a human cutaneous melanoma","volume":"17","author":"Zhang","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/pcmr.12249","article-title":"In melanoma, hippo signaling is affected by copy number alterations and YAP1 overexpression impairs patient survival","volume":"27","author":"Menzel","year":"2014","journal-title":"Pigment Cell. Melanoma Res."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Sarmasti Emami, S., Zhang, D., and Yang, X. (2020). Interaction of the hippo pathway and phosphatases in tumorigenesis. Cancers, 12.","DOI":"10.3390\/cancers12092438"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","article-title":"Targeting the hippo pathway in cancer, fibrosis, wound healing and regenerative medicine","volume":"19","author":"Dey","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Huh, H.D., Kim, D.H., Jeong, H.S., and Park, H.W. (2019). Regulation of TEAD transcription factors in cancer biology. Cells, 8.","DOI":"10.3390\/cells8060600"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5483\/BMBRep.2018.51.3.015","article-title":"DNA binding partners of YAP\/TAZ","volume":"51","author":"Kim","year":"2018","journal-title":"BMB Rep."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"56699","DOI":"10.18632\/oncotarget.11057","article-title":"Regulation of cellular quiescence by YAP\/TAZ and cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse","volume":"7","author":"Corvaisier","year":"2016","journal-title":"Oncotarget"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/pcmr.12700","article-title":"Uveal melanoma driver mutations in GNAQ\/11 yield numerous changes in melanocyte biology","volume":"31","author":"Perez","year":"2018","journal-title":"Pigment Cell. Melanoma Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"e970957","DOI":"10.4161\/23723548.2014.970957","article-title":"YAP inhibition blocks uveal melanogenesis driven by GNAQ Or GNA11 mutations","volume":"2","author":"Lyubasyuk","year":"2014","journal-title":"Mol. Cell. Oncol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1755-148X.2011.00893.x","article-title":"GLI2 and M-MITF transcription factors control exclusive gene expression programs and inversely regulate invasion in human melanoma cells","volume":"24","author":"Javelaud","year":"2011","journal-title":"Pigment Cell. Melanoma Res."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1038\/s41388-020-1362-9","article-title":"The hippo pathway oncoprotein YAP promotes melanoma cell invasion and spontaneous metastasis","volume":"39","author":"Zhang","year":"2020","journal-title":"Oncogene"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/jid.2013.319","article-title":"Pro-invasive activity of the hippo pathway effectors YAP and TAZ in cutaneous melanoma","volume":"134","author":"Marsaud","year":"2014","journal-title":"J. Investig. Dermatol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"11930","DOI":"10.1073\/pnas.1103345108","article-title":"E-cadherin mediates contact inhibition of proliferation through hippo signaling-pathway components","volume":"108","author":"Kim","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.cell.2012.11.027","article-title":"Role of TAZ as mediator of Wnt signaling","volume":"151","author":"Azzolin","year":"2012","journal-title":"Cell"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cell.2014.06.013","article-title":"YAP\/TAZ incorporation in the \u03b2-catenin destruction complex orchestrates the Wnt response","volume":"158","author":"Azzolin","year":"2014","journal-title":"Cell"},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/emboj.2011.487","article-title":"A molecular mechanism that links hippo signalling to the inhibition of Wnt\/\u03b2-catenin signalling","volume":"31","author":"Imajo","year":"2012","journal-title":"EMBO J."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"540","DOI":"10.5483\/BMBRep.2014.47.10.177","article-title":"Cross-talk between Wnt\/\u03b2-catenin and hippo signaling pathways: A brief review","volume":"47","author":"Kim","year":"2014","journal-title":"BMB Rep."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/nature12688","article-title":"A melanocyte lineage program confers resistance to MAP kinase pathway inhibition","volume":"504","author":"Johannessen","year":"2013","journal-title":"Nature"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/2326-6066.CIR-17-0320","article-title":"YAP-induced PD-L1 expression drives immune evasion in BRAFi-resistant melanoma","volume":"6","author":"Kim","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.aaw9886","article-title":"Peritumoral activation of the hippo pathway effectors YAP and TAZ suppresses liver cancer in mice","volume":"366","author":"Moya","year":"2019","journal-title":"Science"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.semcancer.2019.05.010","article-title":"Transcriptional versus metabolic control of cell fitness during cell competition","volume":"63","author":"Lawlor","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2009.02.012","article-title":"Tgf-beta superfamily signaling in embryonic development and homeostasis","volume":"16","author":"Wu","year":"2009","journal-title":"Dev. Cell."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/nrm2297","article-title":"TGFbeta-SMAD signal transduction: Molecular specificity and functional flexibility","volume":"8","author":"Schmierer","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/BCR.0b013e318240541e","article-title":"Epithelial-mesenchymal transition, TGF-\u03b2, and osteopontin in wound healing and tissue remodeling after injury","volume":"33","author":"Weber","year":"2012","journal-title":"J. Burn Care. Res."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","article-title":"Targeting TGF-\u03b2 signaling in cancer","volume":"3","author":"Colak","year":"2017","journal-title":"Trends Cancer"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/jnci\/92.17.1388","article-title":"Role of transforming growth factor-beta signaling in cancer","volume":"92","author":"Piek","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_190","first-page":"2565","article-title":"Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro","volume":"14","author":"Krasagakis","year":"1994","journal-title":"Anticancer Res."},{"key":"ref_191","first-page":"575","article-title":"Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells","volume":"54","author":"Rodeck","year":"1994","journal-title":"Cancer Res."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1755-148X.2008.00450.x","article-title":"Transforming growth factor-beta in cutaneous melanoma","volume":"21","author":"Javelaud","year":"2008","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_193","first-page":"1887","article-title":"Melanoma-associated expression of transforming growth factor-beta isoforms","volume":"148","author":"Rodeck","year":"1996","journal-title":"Am. J. Pathol."},{"key":"ref_194","first-page":"97","article-title":"Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression","volume":"145","author":"Reed","year":"1994","journal-title":"Am. J. Pathol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/jcp.24347","article-title":"Carcinoma-associated fibroblasts: Non-neoplastic tumour-promoting mesenchymal cells","volume":"228","author":"Polanska","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1083\/jcb.200704042","article-title":"Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix","volume":"179","author":"Wipff","year":"2007","journal-title":"J. Cell Biol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cdp.2004.09.003","article-title":"Control of melanoma cell invasion by type IV collagen","volume":"29","author":"Pasco","year":"2005","journal-title":"Cancer Detect. Prev."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/jcb.27681","article-title":"Extracellular matrix (ECM) stiffness and degradation as cancer drivers","volume":"120","author":"Najafi","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2230.2003.01326.x","article-title":"Laminin, hyaluronan, tenascin-C and type VI collagen levels in sera from patients with malignant melanoma","volume":"28","author":"Burchardt","year":"2003","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.4161\/cc.22811","article-title":"Transforming growth factor-\u03b2: Guardian of catabolic metabolism in carcinoma-associated fibroblasts","volume":"11","author":"Khan","year":"2012","journal-title":"Cell. Cycle"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Li, Z., Zhang, J., Zhou, J., Lu, L., Wang, H., Zhang, G., Wan, G., Cai, S., and Du, J. (2019). Nodal facilitates differentiation of fibroblasts to cancer-associated fibroblasts that support tumor growth in melanoma and colorectal cancer. Cells, 8.","DOI":"10.3390\/cells8060538"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nm1448","article-title":"Embryonic and tumorigenic pathways converge via nodal signaling: Role in melanoma aggressiveness","volume":"12","author":"Topczewska","year":"2006","journal-title":"Nat. Med."},{"key":"ref_203","first-page":"2687","article-title":"Microenvironment-driven resistance to B-raf inhibition in a melanoma patient is accompanied by broad changes of gene methylation and expression in distal fibroblasts","volume":"41","author":"Kodet","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Pramong, N., Gojaseni, P., Suttipongkeat, S., Kiattisunthorn, K., and Chittinandana, A. (2020). Diagnostic accuracy of fibroblast growth factor 23 for predicting acute kidney injury in patients with acute decompensated heart failure. Nephrology (Carlton), e13780.","DOI":"10.1111\/nep.13780"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.critrevonc.2015.08.021","article-title":"Targeting oncogenic BRAF and aberrant MAPK activation in the treatment of cutaneous melanoma","volume":"96","author":"Carlino","year":"2015","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.1038\/sj.onc.1207780","article-title":"BRAF alterations are associated with complex mutational profiles in malignant melanoma","volume":"23","author":"Daniotti","year":"2004","journal-title":"Oncogene"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00000372-200310000-00001","article-title":"BRAF mutation: A frequent event in benign, atypical, and malignant melanocytic lesions of the skin","volume":"25","author":"Uribe","year":"2003","journal-title":"Am. J. Dermatopathol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fmolb.2020.00113","article-title":"The current state of molecular testing in the BRAF-mutated melanoma landscape","volume":"7","author":"Vanni","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jid.2016.05.095","article-title":"RASopathy gene mutations in melanoma","volume":"136","author":"Halaban","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fmolb.2020.00172","article-title":"Non-BRAF mutant melanoma: Molecular features and therapeutical implications","volume":"7","author":"Vanni","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.molonc.2007.12.003","article-title":"Human cutaneous melanoma; A review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site","volume":"1","author":"Platz","year":"2008","journal-title":"Mol. Oncol."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Dantonio, P.M., Klein, M.O., Freire, M.R.V.B., Araujo, C.N., Chiacetti, A.C., and Correa, R.G. (2018). Exploring major signaling cascades in melanomagenesis: A rationale route for targetted skin cancer therapy. Biosci. Rep., 38.","DOI":"10.1042\/BSR20180511"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.gde.2006.12.005","article-title":"New insight into BRAF mutations in cancer","volume":"17","author":"Dhomen","year":"2007","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1038\/onc.2017.189","article-title":"Melanocytic nevi and melanoma: Unraveling a complex relationship","volume":"36","author":"Damsky","year":"2017","journal-title":"Oncogene"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/BF01607148","article-title":"Proliferative activity of primary cutaneous melanocytic tumours","volume":"423","author":"Kuwata","year":"1993","journal-title":"Virchows Arch. A Pathol. Anat. Histopathol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0002-9440(10)63736-4","article-title":"Mechanisms of cell-cycle arrest in spitz nevi with constitutive activation of the MAP-kinase pathway","volume":"164","author":"Maldonado","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature03890","article-title":"BRAFE600-associated senescence-like cell cycle arrest of human naevi","volume":"436","author":"Michaloglou","year":"2005","journal-title":"Nature"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/sj.bjc.6603283","article-title":"Cellular senescence in naevi and immortalisation in melanoma: A role for p16?","volume":"95","author":"Cheong","year":"2006","journal-title":"Br. J. Cancer"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ccr.2009.02.022","article-title":"Oncogenic BRAF induces melanocyte senescence and melanoma in mice","volume":"15","author":"Dhomen","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.det.2016.08.001","article-title":"Melanocytic nevi and the genetic and epigenetic control of oncogene-induced senescence","volume":"35","author":"Huang","year":"2017","journal-title":"Dermatol. Clin."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.jid.5700011","article-title":"Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi","volume":"126","author":"Uribe","year":"2006","journal-title":"J. Investig. Dermatol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ccell.2014.11.014","article-title":"MTORC1 activation blocks BRAFV600E-induced growth arrest but is insufficient for melanoma formation","volume":"27","author":"Damsky","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Proietti, I., Skroza, N., Michelini, S., Mambrin, A., Balduzzi, V., Bernardini, N., Marchesiello, A., Tolino, E., Volpe, S., and Maddalena, P. (2020). BRAF Inhibitors: Molecular targeting and immunomodulatory actions. Cancers, 12.","DOI":"10.3390\/cancers12071823"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.18632\/oncotarget.27304","article-title":"The multifaceted anti-cancer effects of BRAF-inhibitors","volume":"10","author":"Croce","year":"2019","journal-title":"Oncotarget"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1084\/jem.20160855","article-title":"An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition","volume":"214","author":"Young","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Diazzi, S., Tartare-Deckert, S., and Deckert, M. (2020). Bad neighborhood: Fibrotic stroma as a new player in melanoma resistance to targeted therapies. Cancers, 12.","DOI":"10.3390\/cancers12061364"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/jcmm.14755","article-title":"Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib","volume":"24","author":"Atzori","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-12-1632","article-title":"Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma","volume":"18","author":"Khalili","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1038\/jid.2015.329","article-title":"BRAF inhibition generates a host-tumor niche that mediates therapeutic escape","volume":"135","author":"Fedorenko","year":"2015","journal-title":"J. Investig. Dermatol."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ccell.2015.03.008","article-title":"Intravital imaging reveals how BRAF inhibition generates drug-tolerant microenvironments with high integrin \u03b21\/FAK signaling","volume":"27","author":"Hirata","year":"2015","journal-title":"Cancer Cell"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/11\/3400\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:34:27Z","timestamp":1760178867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/11\/3400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":230,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11]]}},"alternative-id":["cancers12113400"],"URL":"https:\/\/doi.org\/10.3390\/cancers12113400","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]}}}